nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—ALB—Vismodegib—skin cancer	0.137	0.205	CbGbCtD
Sevoflurane—ALB—Vemurafenib—skin cancer	0.109	0.162	CbGbCtD
Sevoflurane—CYP2E1—Dacarbazine—skin cancer	0.0861	0.128	CbGbCtD
Sevoflurane—CYP2A6—Fluorouracil—skin cancer	0.0765	0.114	CbGbCtD
Sevoflurane—CYP3A4—Temozolomide—skin cancer	0.0621	0.0927	CbGbCtD
Sevoflurane—CYP3A4—Imiquimod—skin cancer	0.0621	0.0927	CbGbCtD
Sevoflurane—ALB—Fluorouracil—skin cancer	0.0488	0.0728	CbGbCtD
Sevoflurane—CYP3A4—Vismodegib—skin cancer	0.0431	0.0642	CbGbCtD
Sevoflurane—CYP3A4—Vemurafenib—skin cancer	0.034	0.0508	CbGbCtD
Sevoflurane—CYP3A4—Docetaxel—skin cancer	0.0117	0.0174	CbGbCtD
Sevoflurane—GABRQ—nerve—skin cancer	0.00768	0.0625	CbGeAlD
Sevoflurane—GRIA1—nerve—skin cancer	0.00695	0.0565	CbGeAlD
Sevoflurane—KCNA1—nerve—skin cancer	0.00678	0.0552	CbGeAlD
Sevoflurane—ATP2C1—skin epidermis—skin cancer	0.00558	0.0454	CbGeAlD
Sevoflurane—ATP2C1—nerve—skin cancer	0.00475	0.0387	CbGeAlD
Sevoflurane—ATP2C1—hair follicle—skin cancer	0.00398	0.0324	CbGeAlD
Sevoflurane—ND1—neck—skin cancer	0.00336	0.0273	CbGeAlD
Sevoflurane—GABRE—hair follicle—skin cancer	0.00298	0.0242	CbGeAlD
Sevoflurane—ATP5D—nipple—skin cancer	0.00273	0.0222	CbGeAlD
Sevoflurane—GABRA3—neck—skin cancer	0.00271	0.022	CbGeAlD
Sevoflurane—ATP2C1—nipple—skin cancer	0.0027	0.022	CbGeAlD
Sevoflurane—GABRP—nipple—skin cancer	0.00265	0.0215	CbGeAlD
Sevoflurane—KCNK3—female reproductive system—skin cancer	0.00245	0.0199	CbGeAlD
Sevoflurane—KCNK10—head—skin cancer	0.00227	0.0184	CbGeAlD
Sevoflurane—KCNK9—head—skin cancer	0.00225	0.0183	CbGeAlD
Sevoflurane—ND1—skin of body—skin cancer	0.00217	0.0177	CbGeAlD
Sevoflurane—KCNK3—head—skin cancer	0.00205	0.0166	CbGeAlD
Sevoflurane—GABRE—nipple—skin cancer	0.00202	0.0164	CbGeAlD
Sevoflurane—ATP5D—connective tissue—skin cancer	0.00194	0.0158	CbGeAlD
Sevoflurane—GABRQ—head—skin cancer	0.00182	0.0148	CbGeAlD
Sevoflurane—ND1—lymphoid tissue—skin cancer	0.00176	0.0143	CbGeAlD
Sevoflurane—ATP2C1—skin of body—skin cancer	0.00173	0.0141	CbGeAlD
Sevoflurane—ND1—female reproductive system—skin cancer	0.0017	0.0138	CbGeAlD
Sevoflurane—GRIA1—head—skin cancer	0.00165	0.0134	CbGeAlD
Sevoflurane—KCNA1—head—skin cancer	0.00161	0.0131	CbGeAlD
Sevoflurane—ATP5D—mammalian vulva—skin cancer	0.0016	0.013	CbGeAlD
Sevoflurane—GABRG3—head—skin cancer	0.0016	0.013	CbGeAlD
Sevoflurane—ATP2C1—mammalian vulva—skin cancer	0.00158	0.0128	CbGeAlD
Sevoflurane—GABRA4—mammalian vulva—skin cancer	0.00156	0.0127	CbGeAlD
Sevoflurane—KCNK2—lymph node—skin cancer	0.00148	0.0121	CbGeAlD
Sevoflurane—ND1—head—skin cancer	0.00142	0.0115	CbGeAlD
Sevoflurane—ATP2C1—lymphoid tissue—skin cancer	0.0014	0.0114	CbGeAlD
Sevoflurane—Conjunctivitis—Imiquimod—skin cancer	0.0014	0.00675	CcSEcCtD
Sevoflurane—Hepatic failure—Dactinomycin—skin cancer	0.00137	0.00665	CcSEcCtD
Sevoflurane—Angiopathy—Vemurafenib—skin cancer	0.00137	0.00663	CcSEcCtD
Sevoflurane—ATP5D—female reproductive system—skin cancer	0.00137	0.0111	CbGeAlD
Sevoflurane—Mediastinal disorder—Vemurafenib—skin cancer	0.00136	0.00659	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Imiquimod—skin cancer	0.00136	0.00657	CcSEcCtD
Sevoflurane—Chills—Vemurafenib—skin cancer	0.00136	0.00656	CcSEcCtD
Sevoflurane—ATP2C1—female reproductive system—skin cancer	0.00135	0.011	CbGeAlD
Sevoflurane—GABRP—female reproductive system—skin cancer	0.00132	0.0108	CbGeAlD
Sevoflurane—GABRD—head—skin cancer	0.00132	0.0108	CbGeAlD
Sevoflurane—Malnutrition—Vemurafenib—skin cancer	0.00132	0.00637	CcSEcCtD
Sevoflurane—Haemoglobin—Imiquimod—skin cancer	0.0013	0.00627	CcSEcCtD
Sevoflurane—Haemorrhage—Imiquimod—skin cancer	0.00129	0.00624	CcSEcCtD
Sevoflurane—Dysgeusia—Vemurafenib—skin cancer	0.00129	0.00623	CcSEcCtD
Sevoflurane—Pharyngitis—Imiquimod—skin cancer	0.00128	0.00619	CcSEcCtD
Sevoflurane—Urinary tract disorder—Imiquimod—skin cancer	0.00127	0.00616	CcSEcCtD
Sevoflurane—GABRG1—head—skin cancer	0.00127	0.0104	CbGeAlD
Sevoflurane—GABRA6—head—skin cancer	0.00127	0.0103	CbGeAlD
Sevoflurane—Urethral disorder—Imiquimod—skin cancer	0.00126	0.00611	CcSEcCtD
Sevoflurane—Asthenia—Vismodegib—skin cancer	0.00125	0.00603	CcSEcCtD
Sevoflurane—Hepatic failure—Temozolomide—skin cancer	0.00124	0.00601	CcSEcCtD
Sevoflurane—GABRB1—head—skin cancer	0.00123	0.01	CbGeAlD
Sevoflurane—Pruritus—Vismodegib—skin cancer	0.00123	0.00595	CcSEcCtD
Sevoflurane—GABRA5—head—skin cancer	0.00123	0.00998	CbGeAlD
Sevoflurane—GABRB3—connective tissue—skin cancer	0.00121	0.00988	CbGeAlD
Sevoflurane—GABRE—mammalian vulva—skin cancer	0.00118	0.00959	CbGeAlD
Sevoflurane—Angiopathy—Imiquimod—skin cancer	0.00117	0.00566	CcSEcCtD
Sevoflurane—Immune system disorder—Imiquimod—skin cancer	0.00116	0.00563	CcSEcCtD
Sevoflurane—Mediastinal disorder—Imiquimod—skin cancer	0.00116	0.00562	CcSEcCtD
Sevoflurane—Chills—Imiquimod—skin cancer	0.00116	0.0056	CcSEcCtD
Sevoflurane—Chest discomfort—Docetaxel—skin cancer	0.00116	0.00559	CcSEcCtD
Sevoflurane—Arrhythmia—Imiquimod—skin cancer	0.00115	0.00557	CcSEcCtD
Sevoflurane—Cough—Vemurafenib—skin cancer	0.00115	0.00556	CcSEcCtD
Sevoflurane—GABRA3—head—skin cancer	0.00114	0.00929	CbGeAlD
Sevoflurane—ATP5D—head—skin cancer	0.00114	0.00929	CbGeAlD
Sevoflurane—Liver function test abnormal—Dactinomycin—skin cancer	0.00114	0.00551	CcSEcCtD
Sevoflurane—Bone disorder—Docetaxel—skin cancer	0.00113	0.00548	CcSEcCtD
Sevoflurane—Mental disorder—Imiquimod—skin cancer	0.00113	0.00546	CcSEcCtD
Sevoflurane—ATP2C1—head—skin cancer	0.00113	0.00917	CbGeAlD
Sevoflurane—Bronchospasm—Bleomycin—skin cancer	0.00113	0.00544	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Docetaxel—skin cancer	0.00112	0.00544	CcSEcCtD
Sevoflurane—Malnutrition—Imiquimod—skin cancer	0.00112	0.00543	CcSEcCtD
Sevoflurane—GABRA4—head—skin cancer	0.00111	0.00906	CbGeAlD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00111	0.00538	CcSEcCtD
Sevoflurane—Oliguria—Docetaxel—skin cancer	0.00111	0.00537	CcSEcCtD
Sevoflurane—GABRP—head—skin cancer	0.00111	0.00899	CbGeAlD
Sevoflurane—Vomiting—Vismodegib—skin cancer	0.00111	0.00535	CcSEcCtD
Sevoflurane—Rash—Vismodegib—skin cancer	0.0011	0.0053	CcSEcCtD
Sevoflurane—Dermatitis—Vismodegib—skin cancer	0.00109	0.0053	CcSEcCtD
Sevoflurane—Anaphylactic shock—Vemurafenib—skin cancer	0.00107	0.0052	CcSEcCtD
Sevoflurane—Nervous system disorder—Vemurafenib—skin cancer	0.00105	0.0051	CcSEcCtD
Sevoflurane—Skin disorder—Vemurafenib—skin cancer	0.00104	0.00505	CcSEcCtD
Sevoflurane—Respiratory failure—Docetaxel—skin cancer	0.00104	0.00504	CcSEcCtD
Sevoflurane—Nausea—Vismodegib—skin cancer	0.00103	0.005	CcSEcCtD
Sevoflurane—Agitation—Imiquimod—skin cancer	0.00103	0.00499	CcSEcCtD
Sevoflurane—GABRE—female reproductive system—skin cancer	0.00101	0.00822	CbGeAlD
Sevoflurane—Syncope—Imiquimod—skin cancer	0.00101	0.00487	CcSEcCtD
Sevoflurane—Hypotension—Vemurafenib—skin cancer	0.001	0.00485	CcSEcCtD
Sevoflurane—ND1—lymph node—skin cancer	0.000993	0.00807	CbGeAlD
Sevoflurane—Loss of consciousness—Imiquimod—skin cancer	0.000986	0.00477	CcSEcCtD
Sevoflurane—Cough—Imiquimod—skin cancer	0.000979	0.00474	CcSEcCtD
Sevoflurane—Cardiac arrest—Fluorouracil—skin cancer	0.000978	0.00473	CcSEcCtD
Sevoflurane—Convulsion—Imiquimod—skin cancer	0.000972	0.0047	CcSEcCtD
Sevoflurane—Hypertension—Imiquimod—skin cancer	0.000969	0.00469	CcSEcCtD
Sevoflurane—Chest pain—Imiquimod—skin cancer	0.000955	0.00462	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000949	0.00459	CcSEcCtD
Sevoflurane—Dry mouth—Imiquimod—skin cancer	0.000934	0.00452	CcSEcCtD
Sevoflurane—GABRB2—head—skin cancer	0.000932	0.00758	CbGeAlD
Sevoflurane—GABRG2—head—skin cancer	0.000932	0.00758	CbGeAlD
Sevoflurane—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000927	0.00449	CcSEcCtD
Sevoflurane—Haemoglobin—Bleomycin—skin cancer	0.00092	0.00445	CcSEcCtD
Sevoflurane—Oedema—Imiquimod—skin cancer	0.000916	0.00443	CcSEcCtD
Sevoflurane—Haemorrhage—Bleomycin—skin cancer	0.000916	0.00443	CcSEcCtD
Sevoflurane—Dysuria—Temozolomide—skin cancer	0.000902	0.00437	CcSEcCtD
Sevoflurane—Shock—Imiquimod—skin cancer	0.000901	0.00436	CcSEcCtD
Sevoflurane—Nervous system disorder—Imiquimod—skin cancer	0.000898	0.00435	CcSEcCtD
Sevoflurane—Tachycardia—Imiquimod—skin cancer	0.000894	0.00432	CcSEcCtD
Sevoflurane—Skin disorder—Imiquimod—skin cancer	0.000889	0.0043	CcSEcCtD
Sevoflurane—Hyperglycaemia—Temozolomide—skin cancer	0.000871	0.00421	CcSEcCtD
Sevoflurane—GABRB3—female reproductive system—skin cancer	0.000856	0.00696	CbGeAlD
Sevoflurane—Hepatitis—Dactinomycin—skin cancer	0.000854	0.00413	CcSEcCtD
Sevoflurane—GABRA2—head—skin cancer	0.000851	0.00692	CbGeAlD
Sevoflurane—Body temperature increased—Vemurafenib—skin cancer	0.000849	0.00411	CcSEcCtD
Sevoflurane—Pharyngitis—Dactinomycin—skin cancer	0.000848	0.0041	CcSEcCtD
Sevoflurane—GABRE—head—skin cancer	0.000844	0.00686	CbGeAlD
Sevoflurane—Insomnia—Imiquimod—skin cancer	0.000828	0.00401	CcSEcCtD
Sevoflurane—Hepatic failure—Docetaxel—skin cancer	0.000826	0.004	CcSEcCtD
Sevoflurane—GABRA1—head—skin cancer	0.000823	0.00669	CbGeAlD
Sevoflurane—Chills—Bleomycin—skin cancer	0.000822	0.00398	CcSEcCtD
Sevoflurane—Dyspnoea—Imiquimod—skin cancer	0.000816	0.00395	CcSEcCtD
Sevoflurane—Somnolence—Imiquimod—skin cancer	0.000814	0.00394	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Temozolomide—skin cancer	0.000814	0.00394	CcSEcCtD
Sevoflurane—ATP5D—lymph node—skin cancer	0.0008	0.00651	CbGeAlD
Sevoflurane—Hypersensitivity—Vemurafenib—skin cancer	0.000791	0.00383	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Imiquimod—skin cancer	0.000791	0.00383	CcSEcCtD
Sevoflurane—ATP2C1—lymph node—skin cancer	0.00079	0.00642	CbGeAlD
Sevoflurane—Atrial fibrillation—Docetaxel—skin cancer	0.000784	0.00379	CcSEcCtD
Sevoflurane—Pain—Imiquimod—skin cancer	0.000783	0.00379	CcSEcCtD
Sevoflurane—Haemoglobin—Temozolomide—skin cancer	0.000776	0.00376	CcSEcCtD
Sevoflurane—Hepatitis—Temozolomide—skin cancer	0.000772	0.00374	CcSEcCtD
Sevoflurane—Haemorrhage—Temozolomide—skin cancer	0.000772	0.00374	CcSEcCtD
Sevoflurane—Conjunctivitis—Fluorouracil—skin cancer	0.000771	0.00373	CcSEcCtD
Sevoflurane—Asthenia—Vemurafenib—skin cancer	0.00077	0.00373	CcSEcCtD
Sevoflurane—Pharyngitis—Temozolomide—skin cancer	0.000767	0.00371	CcSEcCtD
Sevoflurane—Chills—Dactinomycin—skin cancer	0.000766	0.00371	CcSEcCtD
Sevoflurane—Urinary tract disorder—Temozolomide—skin cancer	0.000763	0.00369	CcSEcCtD
Sevoflurane—Pruritus—Vemurafenib—skin cancer	0.00076	0.00368	CcSEcCtD
Sevoflurane—Urethral disorder—Temozolomide—skin cancer	0.000757	0.00366	CcSEcCtD
Sevoflurane—Feeling abnormal—Imiquimod—skin cancer	0.000755	0.00365	CcSEcCtD
Sevoflurane—CYP2B6—skin of body—skin cancer	0.000743	0.00605	CbGeAlD
Sevoflurane—Urticaria—Imiquimod—skin cancer	0.000727	0.00352	CcSEcCtD
Sevoflurane—Body temperature increased—Imiquimod—skin cancer	0.000724	0.0035	CcSEcCtD
Sevoflurane—Cardiac disorder—Temozolomide—skin cancer	0.000717	0.00347	CcSEcCtD
Sevoflurane—GABRB3—head—skin cancer	0.000715	0.00582	CbGeAlD
Sevoflurane—Haemoglobin—Fluorouracil—skin cancer	0.000715	0.00346	CcSEcCtD
Sevoflurane—Haemorrhage—Fluorouracil—skin cancer	0.000712	0.00344	CcSEcCtD
Sevoflurane—Dizziness—Vemurafenib—skin cancer	0.00071	0.00344	CcSEcCtD
Sevoflurane—Pharyngitis—Fluorouracil—skin cancer	0.000706	0.00342	CcSEcCtD
Sevoflurane—Angiopathy—Temozolomide—skin cancer	0.000701	0.00339	CcSEcCtD
Sevoflurane—Immune system disorder—Temozolomide—skin cancer	0.000698	0.00338	CcSEcCtD
Sevoflurane—Mediastinal disorder—Temozolomide—skin cancer	0.000696	0.00337	CcSEcCtD
Sevoflurane—Cough—Bleomycin—skin cancer	0.000696	0.00337	CcSEcCtD
Sevoflurane—Chills—Temozolomide—skin cancer	0.000693	0.00335	CcSEcCtD
Sevoflurane—Liver function test abnormal—Docetaxel—skin cancer	0.000686	0.00332	CcSEcCtD
Sevoflurane—Vomiting—Vemurafenib—skin cancer	0.000683	0.0033	CcSEcCtD
Sevoflurane—Chest pain—Bleomycin—skin cancer	0.000679	0.00328	CcSEcCtD
Sevoflurane—Rash—Vemurafenib—skin cancer	0.000677	0.00328	CcSEcCtD
Sevoflurane—Mental disorder—Temozolomide—skin cancer	0.000677	0.00327	CcSEcCtD
Sevoflurane—Dermatitis—Vemurafenib—skin cancer	0.000676	0.00327	CcSEcCtD
Sevoflurane—Hypersensitivity—Imiquimod—skin cancer	0.000675	0.00326	CcSEcCtD
Sevoflurane—Headache—Vemurafenib—skin cancer	0.000673	0.00325	CcSEcCtD
Sevoflurane—Malnutrition—Temozolomide—skin cancer	0.000672	0.00325	CcSEcCtD
Sevoflurane—Dysgeusia—Temozolomide—skin cancer	0.000658	0.00319	CcSEcCtD
Sevoflurane—Asthenia—Imiquimod—skin cancer	0.000657	0.00318	CcSEcCtD
Sevoflurane—Confusional state—Bleomycin—skin cancer	0.000656	0.00317	CcSEcCtD
Sevoflurane—Anaphylactic shock—Bleomycin—skin cancer	0.000651	0.00315	CcSEcCtD
Sevoflurane—Oedema—Bleomycin—skin cancer	0.000651	0.00315	CcSEcCtD
Sevoflurane—Pruritus—Imiquimod—skin cancer	0.000648	0.00313	CcSEcCtD
Sevoflurane—Nausea—Vemurafenib—skin cancer	0.000638	0.00309	CcSEcCtD
Sevoflurane—Thrombocytopenia—Bleomycin—skin cancer	0.000637	0.00308	CcSEcCtD
Sevoflurane—Arrhythmia—Fluorouracil—skin cancer	0.000636	0.00308	CcSEcCtD
Sevoflurane—Bronchospasm—Docetaxel—skin cancer	0.000631	0.00305	CcSEcCtD
Sevoflurane—Agitation—Temozolomide—skin cancer	0.000618	0.00299	CcSEcCtD
Sevoflurane—Hypotension—Bleomycin—skin cancer	0.000608	0.00294	CcSEcCtD
Sevoflurane—Oedema—Dactinomycin—skin cancer	0.000607	0.00294	CcSEcCtD
Sevoflurane—Dizziness—Imiquimod—skin cancer	0.000606	0.00293	CcSEcCtD
Sevoflurane—CYP2B6—lymphoid tissue—skin cancer	0.000602	0.0049	CbGeAlD
Sevoflurane—GABRA2—lymph node—skin cancer	0.000596	0.00485	CbGeAlD
Sevoflurane—Thrombocytopenia—Dactinomycin—skin cancer	0.000594	0.00287	CcSEcCtD
Sevoflurane—GABRE—lymph node—skin cancer	0.000591	0.00481	CbGeAlD
Sevoflurane—Cough—Temozolomide—skin cancer	0.000587	0.00284	CcSEcCtD
Sevoflurane—Convulsion—Temozolomide—skin cancer	0.000583	0.00282	CcSEcCtD
Sevoflurane—Vomiting—Imiquimod—skin cancer	0.000582	0.00282	CcSEcCtD
Sevoflurane—Hypertension—Temozolomide—skin cancer	0.000581	0.00281	CcSEcCtD
Sevoflurane—CYP2B6—female reproductive system—skin cancer	0.00058	0.00472	CbGeAlD
Sevoflurane—Dyspnoea—Bleomycin—skin cancer	0.00058	0.00281	CcSEcCtD
Sevoflurane—Rash—Imiquimod—skin cancer	0.000577	0.00279	CcSEcCtD
Sevoflurane—Dermatitis—Imiquimod—skin cancer	0.000577	0.00279	CcSEcCtD
Sevoflurane—Headache—Imiquimod—skin cancer	0.000574	0.00278	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000569	0.00275	CcSEcCtD
Sevoflurane—CYP2E1—lymphoid tissue—skin cancer	0.000565	0.00459	CbGeAlD
Sevoflurane—Renal failure—Docetaxel—skin cancer	0.000562	0.00272	CcSEcCtD
Sevoflurane—Dry mouth—Temozolomide—skin cancer	0.00056	0.00271	CcSEcCtD
Sevoflurane—Jaundice—Docetaxel—skin cancer	0.000558	0.0027	CcSEcCtD
Sevoflurane—Pain—Bleomycin—skin cancer	0.000556	0.00269	CcSEcCtD
Sevoflurane—Conjunctivitis—Docetaxel—skin cancer	0.000556	0.00269	CcSEcCtD
Sevoflurane—Confusional state—Temozolomide—skin cancer	0.000553	0.00268	CcSEcCtD
Sevoflurane—Oedema—Temozolomide—skin cancer	0.000549	0.00266	CcSEcCtD
Sevoflurane—Anaphylactic shock—Temozolomide—skin cancer	0.000549	0.00266	CcSEcCtD
Sevoflurane—CYP2E1—female reproductive system—skin cancer	0.000545	0.00443	CbGeAlD
Sevoflurane—Nausea—Imiquimod—skin cancer	0.000544	0.00263	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Docetaxel—skin cancer	0.000541	0.00262	CcSEcCtD
Sevoflurane—ALB—lymph node—skin cancer	0.000539	0.00438	CbGeAlD
Sevoflurane—Nervous system disorder—Temozolomide—skin cancer	0.000538	0.0026	CcSEcCtD
Sevoflurane—Thrombocytopenia—Temozolomide—skin cancer	0.000537	0.0026	CcSEcCtD
Sevoflurane—Convulsion—Fluorouracil—skin cancer	0.000537	0.0026	CcSEcCtD
Sevoflurane—Feeling abnormal—Bleomycin—skin cancer	0.000536	0.00259	CcSEcCtD
Sevoflurane—Skin disorder—Temozolomide—skin cancer	0.000533	0.00258	CcSEcCtD
Sevoflurane—Chest pain—Fluorouracil—skin cancer	0.000527	0.00255	CcSEcCtD
Sevoflurane—Pain—Dactinomycin—skin cancer	0.000519	0.00251	CcSEcCtD
Sevoflurane—Urticaria—Bleomycin—skin cancer	0.000517	0.0025	CcSEcCtD
Sevoflurane—Haemoglobin—Docetaxel—skin cancer	0.000516	0.0025	CcSEcCtD
Sevoflurane—Body temperature increased—Bleomycin—skin cancer	0.000514	0.00249	CcSEcCtD
Sevoflurane—Haemorrhage—Docetaxel—skin cancer	0.000514	0.00249	CcSEcCtD
Sevoflurane—Hepatitis—Docetaxel—skin cancer	0.000514	0.00249	CcSEcCtD
Sevoflurane—Confusional state—Fluorouracil—skin cancer	0.00051	0.00247	CcSEcCtD
Sevoflurane—Pharyngitis—Docetaxel—skin cancer	0.00051	0.00247	CcSEcCtD
Sevoflurane—Urinary tract disorder—Docetaxel—skin cancer	0.000507	0.00245	CcSEcCtD
Sevoflurane—Anaphylactic shock—Fluorouracil—skin cancer	0.000506	0.00245	CcSEcCtD
Sevoflurane—Oedema—Fluorouracil—skin cancer	0.000506	0.00245	CcSEcCtD
Sevoflurane—Urethral disorder—Docetaxel—skin cancer	0.000504	0.00244	CcSEcCtD
Sevoflurane—Feeling abnormal—Dactinomycin—skin cancer	0.0005	0.00242	CcSEcCtD
Sevoflurane—Insomnia—Temozolomide—skin cancer	0.000496	0.0024	CcSEcCtD
Sevoflurane—Nervous system disorder—Fluorouracil—skin cancer	0.000496	0.0024	CcSEcCtD
Sevoflurane—Thrombocytopenia—Fluorouracil—skin cancer	0.000495	0.0024	CcSEcCtD
Sevoflurane—Tachycardia—Fluorouracil—skin cancer	0.000493	0.00239	CcSEcCtD
Sevoflurane—Dyspnoea—Temozolomide—skin cancer	0.000489	0.00237	CcSEcCtD
Sevoflurane—Somnolence—Temozolomide—skin cancer	0.000488	0.00236	CcSEcCtD
Sevoflurane—CYP2B6—head—skin cancer	0.000485	0.00394	CbGeAlD
Sevoflurane—Body temperature increased—Dactinomycin—skin cancer	0.00048	0.00232	CcSEcCtD
Sevoflurane—Hypersensitivity—Bleomycin—skin cancer	0.000479	0.00232	CcSEcCtD
Sevoflurane—Cardiac disorder—Docetaxel—skin cancer	0.000477	0.00231	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Temozolomide—skin cancer	0.000474	0.00229	CcSEcCtD
Sevoflurane—Hypotension—Fluorouracil—skin cancer	0.000472	0.00229	CcSEcCtD
Sevoflurane—Pain—Temozolomide—skin cancer	0.000469	0.00227	CcSEcCtD
Sevoflurane—Asthenia—Bleomycin—skin cancer	0.000467	0.00226	CcSEcCtD
Sevoflurane—Angiopathy—Docetaxel—skin cancer	0.000466	0.00225	CcSEcCtD
Sevoflurane—Immune system disorder—Docetaxel—skin cancer	0.000464	0.00224	CcSEcCtD
Sevoflurane—Mediastinal disorder—Docetaxel—skin cancer	0.000463	0.00224	CcSEcCtD
Sevoflurane—Chills—Docetaxel—skin cancer	0.000461	0.00223	CcSEcCtD
Sevoflurane—Pruritus—Bleomycin—skin cancer	0.00046	0.00223	CcSEcCtD
Sevoflurane—Arrhythmia—Docetaxel—skin cancer	0.000459	0.00222	CcSEcCtD
Sevoflurane—Insomnia—Fluorouracil—skin cancer	0.000457	0.00221	CcSEcCtD
Sevoflurane—CYP2E1—head—skin cancer	0.000455	0.0037	CbGeAlD
Sevoflurane—Feeling abnormal—Temozolomide—skin cancer	0.000452	0.00219	CcSEcCtD
Sevoflurane—Dyspnoea—Fluorouracil—skin cancer	0.000451	0.00218	CcSEcCtD
Sevoflurane—Mental disorder—Docetaxel—skin cancer	0.00045	0.00218	CcSEcCtD
Sevoflurane—Somnolence—Fluorouracil—skin cancer	0.00045	0.00217	CcSEcCtD
Sevoflurane—Malnutrition—Docetaxel—skin cancer	0.000447	0.00216	CcSEcCtD
Sevoflurane—Hypersensitivity—Dactinomycin—skin cancer	0.000447	0.00216	CcSEcCtD
Sevoflurane—CYP3A4—female reproductive system—skin cancer	0.000438	0.00357	CbGeAlD
Sevoflurane—Dysgeusia—Docetaxel—skin cancer	0.000438	0.00212	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000437	0.00211	CcSEcCtD
Sevoflurane—Urticaria—Temozolomide—skin cancer	0.000436	0.00211	CcSEcCtD
Sevoflurane—Asthenia—Dactinomycin—skin cancer	0.000435	0.00211	CcSEcCtD
Sevoflurane—Body temperature increased—Temozolomide—skin cancer	0.000434	0.0021	CcSEcCtD
Sevoflurane—Pain—Fluorouracil—skin cancer	0.000432	0.00209	CcSEcCtD
Sevoflurane—Feeling abnormal—Fluorouracil—skin cancer	0.000417	0.00202	CcSEcCtD
Sevoflurane—Vomiting—Bleomycin—skin cancer	0.000414	0.002	CcSEcCtD
Sevoflurane—Rash—Bleomycin—skin cancer	0.00041	0.00198	CcSEcCtD
Sevoflurane—Dermatitis—Bleomycin—skin cancer	0.00041	0.00198	CcSEcCtD
Sevoflurane—Hypersensitivity—Temozolomide—skin cancer	0.000404	0.00196	CcSEcCtD
Sevoflurane—Urticaria—Fluorouracil—skin cancer	0.000402	0.00194	CcSEcCtD
Sevoflurane—Syncope—Docetaxel—skin cancer	0.000401	0.00194	CcSEcCtD
Sevoflurane—Body temperature increased—Fluorouracil—skin cancer	0.0004	0.00193	CcSEcCtD
Sevoflurane—Asthenia—Temozolomide—skin cancer	0.000394	0.00191	CcSEcCtD
Sevoflurane—Loss of consciousness—Docetaxel—skin cancer	0.000393	0.0019	CcSEcCtD
Sevoflurane—Cough—Docetaxel—skin cancer	0.00039	0.00189	CcSEcCtD
Sevoflurane—Pruritus—Temozolomide—skin cancer	0.000388	0.00188	CcSEcCtD
Sevoflurane—Convulsion—Docetaxel—skin cancer	0.000387	0.00187	CcSEcCtD
Sevoflurane—Nausea—Bleomycin—skin cancer	0.000386	0.00187	CcSEcCtD
Sevoflurane—Hypertension—Docetaxel—skin cancer	0.000386	0.00187	CcSEcCtD
Sevoflurane—Vomiting—Dactinomycin—skin cancer	0.000386	0.00187	CcSEcCtD
Sevoflurane—Rash—Dactinomycin—skin cancer	0.000383	0.00185	CcSEcCtD
Sevoflurane—Chest pain—Docetaxel—skin cancer	0.000381	0.00184	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000378	0.00183	CcSEcCtD
Sevoflurane—Hypersensitivity—Fluorouracil—skin cancer	0.000373	0.0018	CcSEcCtD
Sevoflurane—Dry mouth—Docetaxel—skin cancer	0.000372	0.0018	CcSEcCtD
Sevoflurane—Confusional state—Docetaxel—skin cancer	0.000368	0.00178	CcSEcCtD
Sevoflurane—Oedema—Docetaxel—skin cancer	0.000365	0.00177	CcSEcCtD
Sevoflurane—Anaphylactic shock—Docetaxel—skin cancer	0.000365	0.00177	CcSEcCtD
Sevoflurane—Dizziness—Temozolomide—skin cancer	0.000363	0.00176	CcSEcCtD
Sevoflurane—Nausea—Dactinomycin—skin cancer	0.00036	0.00174	CcSEcCtD
Sevoflurane—Shock—Docetaxel—skin cancer	0.000359	0.00174	CcSEcCtD
Sevoflurane—Nervous system disorder—Docetaxel—skin cancer	0.000358	0.00173	CcSEcCtD
Sevoflurane—Pruritus—Fluorouracil—skin cancer	0.000358	0.00173	CcSEcCtD
Sevoflurane—Thrombocytopenia—Docetaxel—skin cancer	0.000357	0.00173	CcSEcCtD
Sevoflurane—Tachycardia—Docetaxel—skin cancer	0.000356	0.00172	CcSEcCtD
Sevoflurane—Skin disorder—Docetaxel—skin cancer	0.000354	0.00172	CcSEcCtD
Sevoflurane—Vomiting—Temozolomide—skin cancer	0.000349	0.00169	CcSEcCtD
Sevoflurane—Rash—Temozolomide—skin cancer	0.000346	0.00167	CcSEcCtD
Sevoflurane—Dermatitis—Temozolomide—skin cancer	0.000346	0.00167	CcSEcCtD
Sevoflurane—Headache—Temozolomide—skin cancer	0.000344	0.00166	CcSEcCtD
Sevoflurane—Hypotension—Docetaxel—skin cancer	0.000341	0.00165	CcSEcCtD
Sevoflurane—Dizziness—Fluorouracil—skin cancer	0.000334	0.00162	CcSEcCtD
Sevoflurane—Insomnia—Docetaxel—skin cancer	0.00033	0.0016	CcSEcCtD
Sevoflurane—Nausea—Temozolomide—skin cancer	0.000326	0.00158	CcSEcCtD
Sevoflurane—Dyspnoea—Docetaxel—skin cancer	0.000325	0.00157	CcSEcCtD
Sevoflurane—Somnolence—Docetaxel—skin cancer	0.000324	0.00157	CcSEcCtD
Sevoflurane—Vomiting—Fluorouracil—skin cancer	0.000321	0.00156	CcSEcCtD
Sevoflurane—Rash—Fluorouracil—skin cancer	0.000319	0.00154	CcSEcCtD
Sevoflurane—Dermatitis—Fluorouracil—skin cancer	0.000319	0.00154	CcSEcCtD
Sevoflurane—Headache—Fluorouracil—skin cancer	0.000317	0.00153	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Docetaxel—skin cancer	0.000315	0.00152	CcSEcCtD
Sevoflurane—Pain—Docetaxel—skin cancer	0.000312	0.00151	CcSEcCtD
Sevoflurane—Feeling abnormal—Docetaxel—skin cancer	0.000301	0.00146	CcSEcCtD
Sevoflurane—Nausea—Fluorouracil—skin cancer	0.0003	0.00145	CcSEcCtD
Sevoflurane—Body temperature increased—Docetaxel—skin cancer	0.000288	0.0014	CcSEcCtD
Sevoflurane—Hypersensitivity—Docetaxel—skin cancer	0.000269	0.0013	CcSEcCtD
Sevoflurane—Asthenia—Docetaxel—skin cancer	0.000262	0.00127	CcSEcCtD
Sevoflurane—Pruritus—Docetaxel—skin cancer	0.000258	0.00125	CcSEcCtD
Sevoflurane—Dizziness—Docetaxel—skin cancer	0.000241	0.00117	CcSEcCtD
Sevoflurane—Vomiting—Docetaxel—skin cancer	0.000232	0.00112	CcSEcCtD
Sevoflurane—Rash—Docetaxel—skin cancer	0.00023	0.00111	CcSEcCtD
Sevoflurane—Dermatitis—Docetaxel—skin cancer	0.00023	0.00111	CcSEcCtD
Sevoflurane—Headache—Docetaxel—skin cancer	0.000229	0.00111	CcSEcCtD
Sevoflurane—Nausea—Docetaxel—skin cancer	0.000217	0.00105	CcSEcCtD
